Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf039d3790ef46e6aceab46c038baac81> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf039d3790ef46e6aceab46c038baac81 NCIT_P378 "NCI" @default.
- Bf039d3790ef46e6aceab46c038baac81 type Axiom @default.
- Bf039d3790ef46e6aceab46c038baac81 annotatedProperty IAO_0000115 @default.
- Bf039d3790ef46e6aceab46c038baac81 annotatedSource NCIT_C181786 @default.
- Bf039d3790ef46e6aceab46c038baac81 annotatedTarget "A chemoimmunotherapy regimen consisting of cyclophosphamide and epirubicin followed by pembrolizumab, used as a neoadjuvant or adjuvant treatment for HER-2 (EGFR2; ErbB2)-negative and hormone receptor-negative breast cancer." @default.